Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liothyronine (T3) in chronic heart failure with low T3 syndrome
2010-020041-27Phase 2Completed
- Sponsor
- Herlev Hospital
- Start
- Aug 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of liothyronine in euthyroid sick syndrome (NTIS), sponsored by Herlev Hospital. Primary endpoint: Left ventricular systolic function (primary). Started Aug 2010; status: completed.
02
Drugs
liothyronine
03
Conditions
euthyroid sick syndrome (NTIS)
Beyond the preview
Go deeper on 2010-020041-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020041-27.